Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JNJ-78306358 |
Trade Name | |
Synonyms | JNJ 78306358|JNJ78306358 |
Drug Descriptions |
JNJ-78306358 is a bispecific antibody that targets HLA-G expressed on tumor cells and the T-lymphocyte antigen CD3, potentially leading to activation of a cytotoxic T-lymphocyte response against tumor cells (NCI Drug Dictionary). |
DrugClasses | CD3 Antibody 99 |
CAS Registry Number | NA |
NCIT ID | C182073 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
JNJ-78306358 | JNJ-78306358 | 0 | 1 |